Benitec Biopharma Inc. Annual Operating Income (Loss) in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Benitec Biopharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Benitec Biopharma Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.79M, a 1.41% increase year-over-year.
  • Benitec Biopharma Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$22.4M, a 9.97% decline year-over-year.
  • Benitec Biopharma Inc. annual Operating Income (Loss) for 2024 was -$22.5M, a 17.9% decline from 2023.
  • Benitec Biopharma Inc. annual Operating Income (Loss) for 2023 was -$19.1M, a 6.87% decline from 2022.
  • Benitec Biopharma Inc. annual Operating Income (Loss) for 2022 was -$17.9M, a 31.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$22.5M -$3.41M -17.9% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 -$19.1M -$1.23M -6.87% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 -$17.9M -$4.26M -31.3% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-21
2021 -$13.6M -$5.32M -64.2% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-02
2020 -$8.28M -$10.9M -421% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-20
2019 $2.58M Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.